FDA.reportPublic FDA data

atorvastatin calcium 20 MG in 5 mL Oral Suspension

RxCUI
2630760
RxNorm name
atorvastatin calcium 20 MG in 5 mL Oral Suspension
Display name
atorvastatin calcium 20 MG in 5 mL Oral Suspension
Full name
atorvastatin calcium 20 MG in 5 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ATORVALIQATORVALIQCMP Pharma, Inc.41fca2d8-7f3f-45b9-8974-81b89accc2112024-04-27Warnings, Adverse reactionsExact identifier
rxcui: 2630760

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
41fca2d8-7f3f-45b9-8974-81b89accc211atorvastatin calcium 20 MG in 5 mL Oral Suspension [PSN] · atorvastatin 4 MG/ML Oral Suspension [SCD] · atorvastatin (as atorvastatin calcium) 20 MG per 5 ML Oral Suspension [SY]33These highlights do not include all the information needed to use ATORVALIQ safely and effectively. See full prescribing information for ATORVALIQ. ATORVALIQ ® (atorvastatin calcium) oral suspension Initial U.S. Approval: 199620240427